Steris (STE) Earnings Expected to Grow: Should You Buy?

Steris (STE) is anticipated to report Q2 2025 earnings of $2.32 per share, a 14.3% year-over-year increase, on $1.36 billion in revenue, up 6.2%, when it releases results on August 6. Despite a slight 0.1% upward revision in consensus EPS estimates over the past 30 days, the company's negative Zacks Earnings ESP of -3.24% combined with a Zacks Rank of #3 suggests a low probability of an earnings beat, making it not a compelling candidate for an upside surprise despite a history of surpassing consensus EPS in three of the last four quarters.

Analysis

Steris (STE) is positioned to report strong top-and-bottom-line growth for its upcoming quarter, with consensus estimates projecting a 14.3% year-over-year increase in EPS to $2.32 and a 6.2% rise in revenue to $1.36 billion. This positive fundamental outlook, however, is contrasted by bearish near-term quantitative signals. The company's Zacks Earnings ESP (Expected Surprise Prediction) is a negative 3.24%, indicating that the most recent analyst estimates have trended lower than the broader consensus, casting doubt on the likelihood of an earnings beat. Combined with a neutral Zacks Rank #3 (Hold), this configuration makes it difficult to conclusively predict an upside surprise. This data presents a conflict for investors, as the company has a history of outperformance, having beaten consensus EPS estimates in three of the last four quarters, including a notable 5.79% surprise in the most recent period.

Key Decisions for Investors

• Investors should weigh the strong consensus growth forecasts against the negative Zacks Earnings ESP of -3.24%, which suggests a low probability of an earnings surprise and indicates recent analyst sentiment has turned cautious.
• Given the conflicting signals, it may be prudent to avoid establishing new long positions or to consider hedging strategies on existing holdings ahead of the August 6 earnings announcement.
• Focus should be placed on management's commentary during the earnings call, as their discussion of business conditions and forward guidance will likely be more influential on the stock's medium-term trajectory than the initial reaction to a headline beat or miss.